"The ability to quickly create a precise anastomosis with a defined cross sectional area gives the surgeon unprecedented control over flow characteristics. Similar to a drug eluting stent’s ability to prevent intimal hyperplasia, the Optiflow offers control over local healing, addressing one of the major limitations inherent to hand-sewn anastomoses."

David Deaton, MD, FACS
Associate Professor of Surgery & Chief, Endovascular Surgery
Georgetown Hospital

Optiflow Technology

The Optiflow provides a quick and controlled method for joining vessels. The procedure technique mirrors the standard surgical technique and utilizes standard instrumentation. Post-operative care and on-going treatment are the same as a standard arteriovenous fistula.

The symmetrical flow path and atraumatic nature of the Optiflow is designed to address the limitations inherent to traditional purse suturing techniques and may improve clinical outcomes.

Side by Side Histology

Chronic Animal Data

The Optiflow implant pathology (left side) demonstrates a symmetrical open flow path which has been shielded from inflamation and adverse remodeling.

The pathology from a sutured anastomosis (right side) demonstrates narrowing at the anastomosis resulting from purse string suturing, inflammation, and remodeling. This turbulent flow path or jetting effect can cause further narrowing in the vein.

Product Highlights

Precise Control

The Optiflow provides precise control over the geometry of the anastomosis including angle and area.

High Flow

The unique design of the implant results in immediate high flow and sealing.

Non-thrombogenic Material

The Optiflow is manufactured from a proprietary material which has been demonstrated to be non-thrombogenic.